BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33827476)

  • 1. Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review.
    Reece JC; Neal EFG; Nguyen P; McIntosh JG; Emery JD
    BMC Cancer; 2021 Apr; 21(1):373. PubMed ID: 33827476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadequate follow-up of abnormal mammograms.
    McCarthy BD; Yood MU; Boohaker EA; Ward RE; Rebner M; Johnson CC
    Am J Prev Med; 1996; 12(4):282-8. PubMed ID: 8874693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    Martinez-Gutierrez J; Chima S; Boyd L; Sherwani A; Drosdowsky A; Karnchanachari N; Luong V; Reece JC; Emery J
    BMC Cancer; 2023 Jul; 23(1):653. PubMed ID: 37438686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States).
    Jones BA; Dailey A; Calvocoressi L; Reams K; Kasl SV; Lee C; Hsu H
    Cancer Causes Control; 2005 Sep; 16(7):809-21. PubMed ID: 16132791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linked claims and medical records for cancer case management : evaluation of mammography abnormalities.
    Eberl MM; Watroba N; Reinhardt M; Pomerantz J; Serghany J; Broffman G; Fox CH; Mahoney MC; Edge SB
    Cancer; 2007 Aug; 110(3):518-24. PubMed ID: 17577210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.
    McCarthy AM; Kim JJ; Beaber EF; Zheng Y; Burnett-Hartman A; Chubak J; Ghai NR; McLerran D; Breen N; Conant EF; Geller BM; Green BB; Klabunde CN; Inrig S; Skinner CS; Quinn VP; Haas JS; Schnall M; Rutter CM; Barlow WE; Corley DA; Armstrong K; Doubeni CA;
    Am J Prev Med; 2016 Oct; 51(4):507-12. PubMed ID: 27132628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.
    Vang SS; Dunn A; Margolies LR; Jandorf L
    J Gen Intern Med; 2022 May; 37(7):1619-1625. PubMed ID: 35212876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review.
    Vang S; Margolies LR; Jandorf L
    Prev Chronic Dis; 2018 Nov; 15():E140. PubMed ID: 30447104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
    White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
    Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries.
    Klabunde CN; Sancho-Garnier H; Taplin S; Thoresen S; Ohuchi N; Ballard-Barbash R;
    Int J Qual Health Care; 2002 Dec; 14(6):449-61. PubMed ID: 12515331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a fail-safe system to follow up abnormal mammograms in primary care.
    Grossman E; Phillips RS; Weingart SN
    J Patient Saf; 2010 Sep; 6(3):172-9. PubMed ID: 21491792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Beliefs and Breast Cancer Screening in Rural Appalachia: An Evaluation of the Health Belief Model.
    VanDyke SD; Shell MD
    J Rural Health; 2017 Sep; 33(4):350-360. PubMed ID: 27545099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.
    Taif S; Tufail F; Alnuaimi AS
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e250-8. PubMed ID: 24673798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of follow-up after abnormal screening and diagnostic mammograms.
    Wernli KJ; Aiello Bowles EJ; Haneuse S; Elmore JG; Buist DS
    Am J Manag Care; 2011 Feb; 17(2):162-7. PubMed ID: 21473665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women.
    Percac-Lima S; Ashburner JM; McCarthy AM; Piawah S; Atlas SJ
    J Womens Health (Larchmt); 2015 Feb; 24(2):138-43. PubMed ID: 25522246
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.